Insider plans Rule 144 sale of 10,200 DTIL shares

DTIL received a Rule 144 notice for a planned sale of 10,200 shares of its common stock through Fidelity Brokerage Services LLC on 01/21/2026, to be sold on NASDAQ with an aggregate market value of $41,073.36.

Rhea-AI Filing Summary

DTIL received a Rule 144 notice for a planned sale of 10,200 shares of its common stock through Fidelity Brokerage Services LLC on 01/21/2026, to be sold on NASDAQ with an aggregate market value of $41,073.36. These shares were acquired from the issuer on 01/20/2026 through restricted stock vesting as compensation on the same date. The filing notes that the seller represents they are not aware of any material adverse, non-public information about the issuer’s current or prospective operations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the DTIL Form 144 filing disclose?

The Form 144 for DTIL discloses a planned sale of 10,200 shares of common stock under Rule 144, to be sold on NASDAQ through Fidelity Brokerage Services LLC with an aggregate market value of $41,073.36.

How many DTIL shares are planned to be sold and at what value?

The notice covers 10,200 shares of DTIL common stock with an aggregate market value of $41,073.36, according to the filing’s securities information table.

When were the DTIL shares acquired and how?

The 10,200 common shares were acquired on 01/20/2026 via restricted stock vesting from the issuer, with the nature of payment listed as compensation on the same date.

When is the DTIL Rule 144 sale expected to occur?

The filing lists an approximate date of sale of 01/21/2026 for the planned sale of 10,200 DTIL common shares on NASDAQ.

How many DTIL shares are reported as outstanding in the Form 144?

The Form 144 lists 13,256,751 shares of DTIL common stock as outstanding in the securities information section.

What representation does the DTIL seller make in the Form 144?

The person for whose account the securities are to be sold represents that they do not know any material adverse information about DTIL’s current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/21/2026 - 04:14 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001770169
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	PRECISION BIOSCIENCES INC
SEC File Number	001-38841
Address of Issuer	302 EAST PETTIGREW STREET SUITE A-100 DURHAM NORTH CAROLINA 27701
Phone	919-314-5512
Name of Person for Whose Account the Securities are To Be Sold	SMITH J. JEFFERSON
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	10200	41073.36	13256751	01/21/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/20/2026	Restricted Stock Vesting	Issuer			10200	01/20/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution. Today's sale occurred in the account of the James Jefferson Revocable Trust of which James Jefferson Smith is a trustee and an account stakeholder.
Date of Notice	01/21/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Gary Redman, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for James J. Smith
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)